Institut du Cerveau
Research and medical center focused on basic, translational and clinical neuroscience. Activities include laboratory research, clinical cohorts and trials, specialized technological platforms (genomics, imaging, biobank), clinical diagnostics and multidisciplinary care, and programs to accelerate translation from research to development.
Industries
Nr. of Employees
large (251-1000)
Institut du Cerveau
Paris, Ile-de-France, France, Europe
Patents
Orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications
US-12529114-B2
View DetailsDiet controlled expression of a nucleic acid encoding a pro-apoptotic protein
US-12419971-B2
View DetailsMethod for identification of pathological brain activity from scalp electroencephalogram
US-11684303-B2
View DetailsSystem and methods for consciousness evaluation in non-communicating subjects
US-11559244-B2
View Details
Orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications
US-12529114-B2
View DetailsDiet controlled expression of a nucleic acid encoding a pro-apoptotic protein
US-12419971-B2
View DetailsMethod for identification of pathological brain activity from scalp electroencephalogram
US-11684303-B2
View DetailsSystem and methods for consciousness evaluation in non-communicating subjects
US-11559244-B2
View DetailsProducts
Diagnostic sequencing panel (multi-gene kit)
A diagnostic sequencing panel capable of sequencing known disease-associated genes for molecular diagnosis of hereditary neurological disorders.
Diagnostic sequencing panel (multi-gene kit)
A diagnostic sequencing panel capable of sequencing known disease-associated genes for molecular diagnosis of hereditary neurological disorders.
Services
Clinical trial design and execution support for early-phase studies, medical writing and coordination of multidisciplinary clinical assessments.
Multimodal diagnostic evaluations combining neuropsychological testing, neuroimaging, oculomotor recording and neurophysiology to support differential diagnosis and patient stratification.
Design and conduct of neuromodulation studies and iterative stimulation protocols to evaluate therapeutic effects on cognition and motor symptoms.
High-throughput genotyping and sequencing services including multi-gene diagnostic panels and rapid sequencing workflows used for molecular diagnosis and research.
Storage, annotation and provision of DNA and cellular samples for research and clinical projects with certified procedures.
Research and development support for blood-based prion detection assays and downstream validation pathways.
Clinical trial design and execution support for early-phase studies, medical writing and coordination of multidisciplinary clinical assessments.
Multimodal diagnostic evaluations combining neuropsychological testing, neuroimaging, oculomotor recording and neurophysiology to support differential diagnosis and patient stratification.
Design and conduct of neuromodulation studies and iterative stimulation protocols to evaluate therapeutic effects on cognition and motor symptoms.
High-throughput genotyping and sequencing services including multi-gene diagnostic panels and rapid sequencing workflows used for molecular diagnosis and research.
Storage, annotation and provision of DNA and cellular samples for research and clinical projects with certified procedures.
Research and development support for blood-based prion detection assays and downstream validation pathways.
Expertise Areas
- Clinical trial management in neuroscience
- Longitudinal cohort design and cohort management
- Neuroimaging and quantitative image analysis
- Clinical neurophysiology and oculomotor assessment
Key Technologies
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET)
- Functional brain imaging (fMRI, functional PET)
- Electroencephalography (EEG) and intracerebral recordings
News & Updates
Hosted the fifth edition of a charity speedrun marathon to raise funds for neuroscience research.
Announcement that internal platforms received ISO 9001 certification for a quantitative analysis platform and ISO 20387 for the DNA & cells biobank.
Selection of a translational project targeting remyelinating treatment in multiple sclerosis to receive support from the institute's startup studio.
Regulatory authorization was obtained to initiate a phase 2a clinical study of a small-molecule candidate targeting tau phosphorylation in progressive supranuclear palsy; the study includes tolerability, pharmacokinetics and biomarker assessments.
Research teams contributed to development of a biological test able to detect variant prions in blood for diagnosis of prion disease.
Research teams identified new genes implicated in frontotemporal degeneration and other neurogenetic disorders, advancing diagnostic capabilities.
Hosted the fifth edition of a charity speedrun marathon to raise funds for neuroscience research.
Announcement that internal platforms received ISO 9001 certification for a quantitative analysis platform and ISO 20387 for the DNA & cells biobank.
Selection of a translational project targeting remyelinating treatment in multiple sclerosis to receive support from the institute's startup studio.
Regulatory authorization was obtained to initiate a phase 2a clinical study of a small-molecule candidate targeting tau phosphorylation in progressive supranuclear palsy; the study includes tolerability, pharmacokinetics and biomarker assessments.
Research teams contributed to development of a biological test able to detect variant prions in blood for diagnosis of prion disease.
Research teams identified new genes implicated in frontotemporal degeneration and other neurogenetic disorders, advancing diagnostic capabilities.